Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
480.00    7.50 (1.59%)
Bid:
470.00
Ask:
490.00
Spread: 20.00 (4.255%)
Market Cap: £145.07m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

Contract Win

7 Jan 2019 07:00

RNS Number : 3019M
Eagle Eye Solutions Group PLC
07 January 2019
 

 

 

7 January 2019

Eagle Eye Solutions Group PLC

 

("Eagle Eye" or the "Company")

 

Eagle Eye signs a five-year contract with Waitrose & Partners

 

Eagle Eye, a leading SaaS technology company that allows businesses to create a real-time connection with their customers through digital promotion and loyalty services, is delighted to announce a new five-year contract with Waitrose Limited ("Waitrose & Partners").

 

The employee owned British supermarket chain will be taking advantage of Eagle Eye's AIR platform to improve their digital marketing proposition. 

 

This contract signing extends Eagle Eye's existing relationship with John Lewis Plc ("John Lewis") that was first announced in May 2017, enabling the platform to connect to all customers across the group.

 

The Company continues to trade in-line with the Board's expectations.

 

 

Tim Mason, CEO of Eagle Eye, commented: "We are delighted to have won this contract with Waitrose & Partners following on from the work we have done with myJL for John Lewis and look forward to deploying our Eagle Eye AIR platform across their network of stores to drive value through personalised promotions and rewards."

 

About Eagle Eye

Eagle Eye is a leading SaaS marketing technology company that enables businesses to create a real-time connection to attract and retain customers, through digital promotion and loyalty services.

 

The Company's digital marketing platform, Eagle Eye AIR, enables the secure issuance and redemption of digital offers and rewards at scale, across multiple channels, enabling a single customer view. Our platform creates a network between merchants, distributors and brands to enable stronger connections and value for all parties, allowing them to reduce cost, improve their customer offer and accelerate their marketing innovation.

 

The Company's current customer base comprises leading names in UK Grocery, Retail and Food & Beverage, including John Lewis, Asda, J Sainsbury, Greggs, JD Sports, Marks & Spencer, Mitchells & Butlers, Pizza Express, Tesco and Loblaw in Canada.

For more information, please visit www.eagleeye.com

 

For further information, please contact:

Tim Mason, Chief Executive Officer

Lucy Sharman-Munday, Chief Financial Officer

 

Tel: 0844 824 3686

Investec (Nominated Advisor and Joint Broker)

Corporate Finance: David Anderson / Sebastian Lawrence

Corporate Broking: Sara Hale / Helene Comitis

 

Tel: 020 7597 5970

 

Shore Capital (Joint Broker)

 

Hugh Morgan/ Patrick Castle/ Daniel Bush

Tel: 020 7408 4090

Alma PR

Caroline Forde / Rebecca Sanders-Hewett / Robyn Fisher

 

Tel: 020 8004 4217

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTCKADNBBKDBDK
Date   Source Headline
28th May 20267:00 amRNSSale of shares from treasury
21st May 20262:47 pmRNSPDMR shareholding & issue of equity - replacement
21st May 20261:35 pmRNSPDMR shareholding and issue of equity
21st May 20267:00 amRNSCapital Markets Day
27th Apr 20267:00 amRNSNotice of Capital Markets Day
24th Apr 202612:30 pmRNSPDMR Shareholding
23rd Apr 20268:11 amRNSPDMR shareholding and issue of equity
31st Mar 20262:02 pmRNSPCA Shareholding
20th Mar 202610:36 amRNSDirector/PDMR Shareholding
17th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20267:00 amRNSHalf Year Results
17th Mar 20267:00 amRNSHalf Year Results
6th Mar 20267:00 amRNSTransaction in Own Shares & Programme Completion
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSNotification of major holdings
2nd Mar 20262:43 pmRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20263:32 pmRNSDirector/PDMR Shareholding
12th Feb 202610:59 amRNSDirector/PDMR Shareholding
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSExtension of Share Buyback Long Stop Expiry Date
29th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSAppointment of Nominated Adviser and Joint Broker
23rd Jan 20263:48 pmRNSDirector Declaration Update
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSMajor US multi-year contract win
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.